The relationship between systemic inflammation response index and clinical and histopathological features in gastric cancer.

Cirugia y cirujanos Pub Date : 2024-11-25 DOI:10.24875/CIRU.23000234

Hikmet Pehlevan-Özel, Tolga Dinç, Nermin D Okay, Mesut Tez

{"title":"The relationship between systemic inflammation response index and clinical and histopathological features in gastric cancer.","authors":"Hikmet Pehlevan-Özel, Tolga Dinç, Nermin D Okay, Mesut Tez","doi":"10.24875/CIRU.23000234","DOIUrl":null,"url":null,"abstract":"Objective: The systemic inflammation response index (SIRI) is a marker used to predict survival. The aim of this study is to examine the relationship between SIRI and clinicopathological features and survival.Method: The relationship between clinicopathological characteristics and survey and SIRI was retrospectively investigated.Results: A total of 178 patients were included in the study. Poor prognostic factors such as tumor size, t, T-stage, tumor-node-metastasis (TNM) stage, and CA19-9 level were found to have a statistically significant relationship with patients with high SIRI (p = 0.039, p = 0.001, p = 0.001 and p = 0.013, respectively). A high SIRI was found to be an independent and poor prognostic factor for 3-year and 5-year survival (p = 0.014 and p = 0.027, respectively).Conclusions: High SIRI was associated with a poor survival rate, as were advanced TNM stage, advanced T stage, larger tumor size, and elevated CA19-9 level; all these are poor prognostic markers for gastric cancer.","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cirugia y cirujanos","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/CIRU.23000234","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: The systemic inflammation response index (SIRI) is a marker used to predict survival. The aim of this study is to examine the relationship between SIRI and clinicopathological features and survival.

Method: The relationship between clinicopathological characteristics and survey and SIRI was retrospectively investigated.

Results: A total of 178 patients were included in the study. Poor prognostic factors such as tumor size, t, T-stage, tumor-node-metastasis (TNM) stage, and CA19-9 level were found to have a statistically significant relationship with patients with high SIRI (p = 0.039, p = 0.001, p = 0.001 and p = 0.013, respectively). A high SIRI was found to be an independent and poor prognostic factor for 3-year and 5-year survival (p = 0.014 and p = 0.027, respectively).

Conclusions: High SIRI was associated with a poor survival rate, as were advanced TNM stage, advanced T stage, larger tumor size, and elevated CA19-9 level; all these are poor prognostic markers for gastric cancer.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

胃癌全身炎症反应指数与临床和组织病理学特征的关系

目的：全身炎症反应指数（SIRI）是一种用于预测生存率的指标。本研究旨在探讨 SIRI 与临床病理特征和生存率之间的关系：方法：回顾性研究临床病理特征和调查与 SIRI 之间的关系：结果：研究共纳入178例患者。研究发现，肿瘤大小、t、T期、肿瘤-结节-转移（TNM）分期和CA19-9水平等不良预后因素与高SIRI患者有显著统计学关系（分别为p = 0.039、p = 0.001、p = 0.001和p = 0.013）。高 SIRI 是 3 年和 5 年生存率的独立且不良预后因素（分别为 p = 0.014 和 p = 0.027）：结论：SIRI高与生存率低有关，TNM分期晚期、T分期晚期、肿瘤体积较大和CA19-9水平升高也与生存率低有关；所有这些都是胃癌的不良预后标志物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Cirugia y cirujanos

自引率

0.00%

发文量